Overview
Karin Blakemore, M.D., is the director of prenatal genetics at the prenatal diagnostic center in the Johns Hopkins Department of Gynecology and Obstetrics, and she is a member of the McKusick-Nathans Institute of Genetic Medicine. Her areas of clinical expertise include fetal imaging and fetal genetic disorders. Dr. Blakemore also serves as a professor of oncology and of gynecology and obstetrics in the Johns Hopkins University School of Medicine. Dr. Blakemore earned her medical degree from the Medical College of Ohio at Toledo. She completed her residency at New York University Medical Center and performed fellowships in genetics at Yale University School of Medicine and in maternal and fetal medicine at Washington University School of Medicine. Her research interests include Fetal Genetic Disorders; Prenatal Diagnosis and Fetal Treatment; In Utero Hematopoietic Stem Cell Transplantation; Hemoglobinopathies; Red cell and platelet alloimmunization; Intrapartum physiology and outcomes; Placental development and abnormalities.
Dr. Blakemore is rated as an Experienced provider by MediFind in the treatment of Methimazole Antenatal Exposure. Her top areas of expertise are HELLP Syndrome, Desbuquois Syndrome, Atypical Hemolytic Uremic Syndrome (aHUS), and Hypochondroplasia.
Her clinical research consists of co-authoring 39 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
Locations
10753 Falls Road, Pavilion II Suite 245, Pavilion II Suite 245, Lutherville, MD 21093
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Richard Broth is a Neonatologist and an Obstetrics and Gynecologist in Silver Spring, Maryland. Dr. Broth is rated as an Advanced provider by MediFind in the treatment of Methimazole Antenatal Exposure. His top areas of expertise are Methimazole Antenatal Exposure, Premature Infant, Gestational Diabetes, and Cervical Polyps. Dr. Broth is currently accepting new patients.
Maryland Perinatal Associates
Wayne Kramer, M.D. completed medical school at the University of Witwatersrand Medical School in Johannesburg, South Africa and completed his obstetrics and gynecology residency and maternal-fetal medicine fellowship at Baylor College of Medicine in Houston, Texas. Dr. Kramer is a member of the American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine and American Medical Informatics Association. Dr. Kramer is rated as an Advanced provider by MediFind in the treatment of Methimazole Antenatal Exposure. His top areas of expertise are Placental Insufficiency, Methimazole Antenatal Exposure, Gestational Diabetes, and Placenta Previa.
Maryland Perinatal Associates
Christopher Young, M.D. completed his masters in public health from Harvard University in Cambridge, Massachusetts and medical school at Duke University in Durham, North Carolina. He completed his obstetrics and gynecology residency at Northwestern University in Chicago, Illinois and his maternal-fetal medicine fellowship at University of California, Irvine in Orange, California. Dr. Young is a member of the American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine and the National Medical Association. Dr. Young has an interest in multiple gestation, HIV, preterm labor and hypertension. Dr. Young is rated as an Advanced provider by MediFind in the treatment of Methimazole Antenatal Exposure. His top areas of expertise are Methimazole Antenatal Exposure, Placental Insufficiency, Polyhydramnios, and Gestational Diabetes.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Desbuquois SyndromeDr. Blakemore isAdvanced. Learn about Desbuquois Syndrome.
- HELLP SyndromeDr. Blakemore isAdvanced. Learn about HELLP Syndrome.
- Experienced
- Achalasia Microcephaly SyndromeDr. Blakemore isExperienced. Learn about Achalasia Microcephaly Syndrome.
- Atypical Hemolytic Uremic Syndrome (aHUS)Dr. Blakemore isExperienced. Learn about Atypical Hemolytic Uremic Syndrome (aHUS).
- HypochondroplasiaDr. Blakemore isExperienced. Learn about Hypochondroplasia.
- Methimazole Antenatal ExposureDr. Blakemore isExperienced. Learn about Methimazole Antenatal Exposure.
- OmphaloceleDr. Blakemore isExperienced. Learn about Omphalocele.
- Paroxysmal Nocturnal Hemoglobinuria (PNH)Dr. Blakemore isExperienced. Learn about Paroxysmal Nocturnal Hemoglobinuria (PNH).